The median value of lnc‐ITSN1‐2 expression was 2.421 (1.361‐4.274) in AIS patients and 1.098 (0.587‐1.798) in the controls, and its expression was increased in AIS patients compared with the controls (P < .001; Figure 1A). Here, ITSN1 is linked to androgen insensitivity syndrome.